Structural changes of vitamin D receptor induced by 20-epi-1α,25-(OH)2D3: An insight from a computational analysis

Journal of Steroid Biochemistry and Molecular Biology

Volumn 113, Issue 3-5, 2009, Pages 253-258

  Sicinska, Wanda ^a   Rotkiewicz, Piotr ^b  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Poland)

^b BURNHAM INSTITUTE   (United States)

Author keywords

20 epi Vitamin D analogs; Structure comparisons; Targets for mutational analyses; Vitamin D; Vitamin D receptor

Indexed keywords

20 EPICALCITRIOL; CALCITRIOL; NUCLEAR RECEPTOR COACTIVATOR 2; RETINOID X RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; VITAMIN D RECEPTOR;

ARTICLE; COMPLEX FORMATION; COMPUTER ANALYSIS; CRYSTAL STRUCTURE; GENETIC TRANSCRIPTION; PROTEIN CONFORMATION; PROTEIN INTERACTION; RECEPTOR BINDING;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; HUMANS; LIGANDS; MOLECULAR STRUCTURE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CALCITRIOL; REPRODUCIBILITY OF RESULTS; SOFTWARE; TRANSCRIPTION, GENETIC;

EID: 61349112664     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.01.007     Document Type: Article

References (39)

1. 3 receptor permits sensitive interaction with agonists. Mol. Pharmacol. 57 (2000) 1206-1217
2. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., and Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 5 (2000) 173-179
3. Tocchini-Valentini G.D., Rochel N., Wurtz J.M., Mitschler A., and Moras D. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5491-5496
4. Ciesielski F., Rochel N., and Moras D. Adaptability of the vitamin D nuclear receptor to the synthetic ligand Gemini: remodeling the LBP with one side chain rotation. J. Steroid. Biochem. Mol. Biol. 103 (2007) 235-242
5. 3 hormone analogues and a LXXLL-containing co-activator peptide. Biochemistry 43 (2004) 4101-4110
6. Rochel N., and Moras D. Ligand binding domain of vitamin D receptors. Curr. Top. Med. Chem. 6 (2006) 1229-1241
7. 3 for the study of specific functions of vitamin D. J. Steroid Biochem. Mol. Biol. 103 (2007) 263-268
8. H.F. DeLuca, J. Wicha, 20(S)-25-hydroxy vitamin D compounds, US Patent 5,840,938. (1998).
9. 3 receptor. J. Biol. Chem. 274 (1999) 16838-16845
10. Yamada S., Shimizu M., and Yamamoto K. Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor. Med. Res. Rev. 23 (2003) 89-115
11. Weyts F.A., Dhawan P., Zhang X., Bishop J.E., Uskokovic M.R., Ji Y., Studzinski G.P., Norman A.W., and Christakos S. Novel Gemini analogs of 1α,25-dihydroxyvitamin D3 with enhanced transcriptional activity. Biochem. Pharmacol. 67 (2004) 1327-1336
12. Sicinska W., and Rotkiewicz P. Computational analysis of the active sites in binary and ternary complexes of the vitamin D receptor. Conference Communicate on 13th Workshop on Vitamin D, Special Issue. J. Steroid Biochem. Mol. Biol. 103 (2007) 305-309
13. Biodesigner Molecular Modeling Visualization Program, http://www.pirx.com
14. CCOMP version 3.30, http://www.pirx.com/ccomp
15. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., and Thompson J.D. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31 (2003) 3497-3500 (CLUSTAL W)
16. γ monitored by NMR spectroscopy: implications for nuclear receptor activation. J. Mol. Biol. 298 (2000) 187-194
17. Sicinska W. DFT calculation of nitrogen chemical shifts in the active site of vitamin D receptor. Polish J. Chem. 80 (2006) 1177-1183
18. Sicinska W., Westler W.M., and DeLuca H.F. NMR assignments of tryptophan residue in apo and holo LBD-rVDR. Proteins 61 (2005) 461-467
19. Dunbrack R.L. Rotamer libraries in the 21st century. Curr. Opin. Struct. Biol. 12 (2002) 431-440
20. Lovell S.C., Word J.M., Richardson J.S., and Richardson D.C. Asparagine and glutamine rotamers: B-factor cutoff and correction of amide flips yield distinct clustering. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 400-405
21. Radivojac P., Obradovic Z., Smith D.K., Zhu G., Vucetic S., Brown C.J., Lawson J.D., and Dunker A.K. Protein flexibility and intrinsic disorder. Protein Sci. 13 (2004) 71-80
22. Feng W., Ribeiro R.C.J., Wagner R.L., Nguyen H., Apriletti J.W., Fletteric R.J., Baxter J.D., Kushner P.J., and West B.L. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280 (1998) 1747-1749
23. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., and Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395 (1998) 137-143
24. 3 and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties. Mol. Cell. Biol. 19 (1999) 5486-5494
25. Vaisanen S., Ryhanen S., Saarela J.T.A., Perakyla M., Andersin T., and Maenpaa P.H. Structurally and functionally important amino acids of the agonistic conformation of the human vitamin D receptor. Mol. Pharmacol. 62 (2002) 788-794
26. Malloy P.J., Xu R., Cattani A., Reyes L., and Feldman D. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets. J. Bone Miner. Res. 19 (2004) 1018-1024
27. http://www.usm.maine.edu/∼rhodes/SPVTut/text/STut09aTN.html.
28. W. Kabsh, C. Sander, DSSP, updated CMBI version by ElmK, 1982.
29. Chothia C. The nature of the accessible and buried surfaces in proteins. J. Mol. Biol. 105 (1976) 1-14
30. SYBYL Modeling Program, 7.1 ed., Tripos Inc., St. Louis, MO, 2005.
31. 3 with two side chains: interaction with its nuclear receptor and cellular actions. J. Med. Chem. 43 (2000) 2719-2730
32. Rajamani D., Thiel S., Vajda S., and Camacho C.J. Anchor residues in protein-protein interactions. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 11287-11292
33. Germain P., Staels B., Dacquet C., Spedding M., and Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 58 (2006) 685-704
34. Barry J.B., Leong G.M., Church W.B., Issa L.L., Eisman J.A., and Gardiner E.M. Interactions of SKIP/NCoA-62, TFIIB and retinoid X receptor with vitamin D receptor helix H10 residues. J. Biol. Chem. 278 (2003) 8224-8228
35. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., and Yamamoto K.R. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12 (1998) 3343-3356
36. MacDonald P.N., Dowd D.R., Zhang C., and Gu C. Emerging insights into the coactivator role of NCoA62/SKIP in vitamin D-mediated transcription. J. Steroid. Biochem. Mol. Biol. 89-90 (2004) 179-186
37. Feng W., Ribeiro R.C.J., Wagner R.L., Nguyen H., Apriletti J.W., Fletterick J., Baxter J.D., Kushner P.J., and West B.L. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280 (1998) 1747-1749
38. Shah S., Islam Md.N., Dakshanamurthy S., Rizvi I., Rao M., Herrell R., Zinser G., Valrance M., Aranda A., Moras D., Norman A., Welsh J., and Byers S.W. The molecular basis of vitamin D receptor and β-catenin crossregulation. Mol. Cell 21 (2006) 799-809
39. 3 receptor preferentially recruits the coactivator SRC-1 during up-regulation of the osteocalcin gene. J. Steroid Biochem. Mol. Biol. 103 (2007) 420-424